Results 171 to 180 of about 75,323 (218)

Metronomic (mCHT) vs standard (sCHT) chemotherapy as first-line treatment in HR+/HER2- Metastatic Breast Cancer (MBC) patients following failure of endocrine treatments. The matched control VICTOR-15 study. [PDF]

BMC Cancer
Cazzaniga ME, Galimberti S, Pepe FF, Cogliati V, Sandretti F, Capici S.   +5 more
europepmc   +1 more source

Case Report: HER2-positive vulvar Paget disease achieving long-term control with trastuzumab-based systemic therapy plus radiotherapy. [PDF]

Front Med (Lausanne)
Xie X, Chen Q, Zhang J, Peng X.
europepmc   +1 more source

Camrelizumab plus CAPOX with camrelizumab based maintenance versus CAPOX alone as initial treatment for gastric or gastro-oesophageal junction adenocarcinoma: randomised phase 3 trial.

BMJ
Peng Z, Zhang Y, Xu H, Yang Y, Yang M, Zhang M, Cheng Y, Chen X, Pan Y, Wang F, Li Q, Xu N, Liu L, Gu K, Xiao J, Zhang R, Zhao Q, Chen J, Lin L, Chen Y, Deng Y, Cai S, Bai B, Wang Y, Shen L.   +24 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Capecitabine

Drugs, 1999
Capecitabine is an orally administered fluoropyrimidine carbamate used for the treatment of paclitaxel- or anthracycline-refractory breast cancer. Capecitabine is metabolised via a 3-step process to the active agent fluorouracil. The final step of this process occurs preferentially in malignant tissue.
M, Dooley, K L, Goa
openaire   +3 more sources

Capecitabine

Investigational New Drugs, 2000
Drug development has undergone rapid shifts in methodology and the use of rationally derived agents which either target specific tissues or molecules such as receptors or enzymatic sites. Capecitabine is a rationally derived prodrug of 5-fluorouracil which is based upon the known high concentration of the enzyme thymidine phosphorylase in many human ...
openaire   +3 more sources

Capecitabine

Reactions Weekly, 2023
  +4 more sources

Capecitabine

Reactions Weekly, 2020
  +4 more sources

Capecitabine leukoencephalopathy

Practical Neurology, 2019
Zeid, Yasiry, Mahdia S, Obeda, Ruth, Batty, Basil, Sharrack   +3 more
openaire   +2 more sources

Capecitabine

Reactions Weekly, 2010
  +6 more sources